Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2009
12/09/2009CN101600719A Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol
12/09/2009CN101600460A Ultrasound microbubble mediated genes delivery system
12/09/2009CN101600426A Isosorbide mononitrate derivatives for the treatment of intestinal disorders
12/09/2009CN101600425A Isosorbide mononitrate derivatives for the treatment of ocular hypertension
12/09/2009CN101600423A Composition for amelioration/prevention of adverse side effect in steroid therapy
12/09/2009CN101600421A Use of erss selective ligands for treating acute lung injuries
12/09/2009CN101597337A Conjugate of hydroxyalkyl starch and an active agent
12/09/2009CN101597294A 3-aminoalkaneacylamino-rutaecarpine and 3-aminoalkaneacylamino-7,8-dehydrorutaecarpine derivative
12/09/2009CN101597280A Compound used as seven-pass transmembrane protein and based on sag structure
12/09/2009CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009CN101596265A Traditional Chinese medicine compound preparation for enhancing body fatigue resistance
12/09/2009CN101596261A Medicament for treating hydrocephalus and preparation method thereof
12/09/2009CN101596260A Chinese patent medicine for treating epilepsy and postpartum epilepsy and preparation method thereof
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009CN101596184A Application of rosmarinic acid as peroxynitrite inhibitor
12/09/2009CN100567489C Antiallergic agent and pharmaceutical use thereof
12/09/2009CN100567488C Enhancement of virus-mediated DNA transfer
12/09/2009CN100567289C 2-(hetero)aryl substituted tetrahydroquinoline derivatives
12/09/2009CN100567253C Novel succinate salt of O-demethyl-venlafaxine
12/09/2009CN100567242C Hsp90 family protein inhibitors
12/09/2009CN100566728C Method for extracting bitter buckwheat flavone in high purity
12/09/2009CN100566723C Carbohydrase inhibitors derived from chestnut and use thereof
12/09/2009CN100566719C Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients
12/09/2009CN100566591C Bait used specially for atlantic trout
12/08/2009US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide
12/08/2009US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009US7629456 Modified L-nucleic acid
12/08/2009US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly
12/08/2009US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
12/08/2009US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
12/08/2009US7629366 Aminoalcohol derivatives
12/08/2009US7629363 Diaryl substituted pyridinones
12/08/2009US7629362 2-pyridine carboxamide derivatives
12/08/2009US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
12/08/2009US7629341 Human ADAM-10 inhibitors
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009US7629326 Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage site
12/08/2009US7629321 Oligoribonucleotides and ribonucleases for cleaving RNA
12/08/2009US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo
12/08/2009US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
12/08/2009US7628983 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
12/08/2009CA2485916C Non-nucleoside reverse transcriptase inhibitors
12/08/2009CA2482311C Furyl compounds
12/08/2009CA2440744C Il-12 expression controlling agent
12/08/2009CA2434829C New benzoylguanidine salt
12/08/2009CA2422807C N-substituted benzothiophenesulfonamide derivatives
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009CA2415486C Pyramidine derivatives
12/08/2009CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009CA2381801C Phosphonic acid derivative having inhibitory activity against carboxypeptidase b
12/08/2009CA2375986C Substituted pyrazole compounds
12/08/2009CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/08/2009CA2373183C Iminocyclitol inhibitors of hexoaminidase and glycosidase
12/08/2009CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/08/2009CA2358289C Amide derivatives for antiangiogenic and/or antitumorigenic use
12/08/2009CA2355075C Heteroaryl-cyclic acetals
12/08/2009CA2340952C Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
12/08/2009CA2333475C Derivatives of pyrazolines, their preparation and their application as medicaments
12/08/2009CA2315113C Pyridones as src family sh2 domain inhibitors
12/08/2009CA2314613C Azolo triazines and pyrimidines
12/08/2009CA2266584C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/08/2009CA2263898C Composition and method for repairing neurological tissue
12/03/2009WO2009146153A2 Manufacture, transport and delivery of material containing highly polarized nuclei
12/03/2009WO2009145852A1 Tricyclic benzo[5,6]cyclohepta[1,2-b]pyridine derivatives and uses thereof
12/03/2009WO2009145289A1 Inhibitor of analgesic tolerance
12/03/2009WO2009145238A1 Immunomodulatory agent and use thereof
12/03/2009WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009WO2009145177A1 Donepezil-containing patch preparation and packaging thereof
12/03/2009WO2009145171A1 Novel benzothiophene oxide derivative and salt thereof
12/03/2009WO2009144961A1 Substituted carbinol compound having cyclic linker
12/03/2009WO2009144933A1 Apoptosis inducer
12/03/2009WO2009144577A2 Anionic polyamide functionalized by a tryptophan unit
12/03/2009WO2009144278A2 USES OF CONGLUTIN-γ
12/03/2009WO2009103218A8 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
12/03/2009WO2009032888A3 Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract
12/03/2009US20090299268 Topical Aminolevulinic Acid-Photodynamic Therapy for the Treatment of Acne Vulgaris
12/03/2009US20090298946 Local Anesthetic Deactivation
12/03/2009US20090298939 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals
12/03/2009US20090298936 Method for energizing human beings
12/03/2009US20090298922 Aav transduction of muscle tissue
12/03/2009US20090298921 Methods and compositions for use in homologous recombination
12/03/2009US20090298876 Modulators of atp-binding cassette transporters
12/03/2009US20090298873 Methods of reducing microbial resistance to drugs
12/03/2009US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells
12/03/2009US20090298841 serotonin receptor modulators such as 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline, used for treating obesity, nervous system disorders such as dementia, schizophrenia and Alzheimer's disease, and as cognition activators
12/03/2009US20090298791 Combinations comprising epothilones and antimetabolites
12/03/2009US20090298789 arresting heart of subject in need of heart surgery by exposing heart to effective amounts of a compound chosen from a potassium channel opener, a potassium channel agonist, an adenosine receptor agonist, and a local anaesthetic under conditions sufficient for heart to be arrested
12/03/2009US20090298775 Method of measuring neprilysin activity
12/03/2009US20090298762 Conjugates of biologically active proteins having a modified in vivo half-life
12/03/2009US20090298743 Hydrophobic compositions containing reconstitution enhancer
12/03/2009US20090298120 Method for expressing sialylated glycoproteins in mammalian cells and cells thereof
12/03/2009US20090297644 Herbal compositions for the treatment of diseases of the oral cavity
12/03/2009US20090297641 Herbal compositions for the treatment of mucosal lesions
12/03/2009US20090297598 Therapeutic combination
12/03/2009US20090297597 Modified Release Ticlopidine Compositions
12/03/2009US20090297591 Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds